- Home
- Publications
- Publication Search
- Publication Details
Title
Renal and extrarenal effects of fibroblast growth factor 23
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 15, Issue 2, Pages 109-120
Publisher
Springer Nature
Online
2018-12-05
DOI
10.1038/s41581-018-0087-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGF23 impairs peripheral microvascular function in renal failure
- (2018) Melissa Verkaik et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients
- (2018) David E. Leaf et al. Clinical Journal of the American Society of Nephrology
- Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
- (2018) Rafiou Agoro et al. FASEB JOURNAL
- Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
- (2018) Amarnath Marthi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23
- (2018) Isao Matsui et al. KIDNEY INTERNATIONAL
- FGF23 effects on the heart—levels, time, source, and context matter
- (2018) Christian Faul KIDNEY INTERNATIONAL
- The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
- (2018) Eva-Maria Pastor-Arroyo et al. KIDNEY INTERNATIONAL
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
- (2018) Markus Ketteler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Burosumab Therapy in Children with X-Linked Hypophosphatemia
- (2018) Thomas O. Carpenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population
- (2018) Adrian Covic et al. Lancet Diabetes & Endocrinology
- FGF23 Actions on Target Tissues—With and Without Klotho
- (2018) Beatrice Richter et al. Frontiers in Endocrinology
- Role of Fibroblast Growth Factor-23 in Innate Immune Responses
- (2018) Elizabeth A. Fitzpatrick et al. Frontiers in Endocrinology
- Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications
- (2018) Mayte Medrano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling
- (2018) Gaozhi Chen et al. NATURE
- Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study
- (2017) Junichi Ishigami et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Longitudinal FGF23 Trajectories and Mortality in Patients with CKD
- (2017) Tamara Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
- (2017) Jair Munoz Mendoza et al. KIDNEY INTERNATIONAL
- Vascular calcification in chronic kidney disease: different bricks in the wall?
- (2017) Marc Vervloet et al. KIDNEY INTERNATIONAL
- Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
- (2017) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase
- (2017) Ingo Flamme et al. PLoS One
- Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease
- (2017) Kazuki Kawakami et al. Scientific Reports
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
- (2017) Alexander Grabner et al. Scientific Reports
- Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
- (2017) Svetlana Slavic et al. Scientific Reports
- Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression
- (2016) Janak L. Pathak et al. CALCIFIED TISSUE INTERNATIONAL
- Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients
- (2016) Margarida Sarmento-Dias et al. CLINICAL NEPHROLOGY
- Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy
- (2016) Yuichi Takashi et al. ENDOCRINE RESEARCH
- Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2D in macrophages
- (2016) Xiaobin Han et al. FEBS LETTERS
- FGF23 signaling impairs neutrophil recruitment and host defense during CKD
- (2016) Jan Rossaint et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults
- (2016) Kristen L. Nowak et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23: fueling the fire
- (2016) Mark Hanudel et al. KIDNEY INTERNATIONAL
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery
- (2016) David E. Leaf et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
- (2016) Saurav Singh et al. KIDNEY INTERNATIONAL
- The role of phosphate in kidney disease
- (2016) Marc G. Vervloet et al. Nature Reviews Nephrology
- Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells
- (2016) Beatrice Richter et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- The mechanisms underlying the beneficial effects of exercise on bone remodeling: Roles of bone-derived cytokines and microRNAs
- (2016) Zhengtang Qi et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study
- (2016) Robin Haring et al. Journal of the American Heart Association
- Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
- (2016) Rupal Mehta et al. JAMA Cardiology
- Expression of Fgf23 in Activated Dendritic Cells and Macrophages in Response to Immunological Stimuli in Mice
- (2015) Yuki Masuda et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Hunt for the culprit of cardiovascular injury in kidney disease: Figure 1
- (2015) Christian Faul et al. CARDIOVASCULAR RESEARCH
- Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue
- (2015) Rik Mencke et al. CARDIOVASCULAR RESEARCH
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View
- (2015) H. J. Lambers Heerspink et al. Clinical Journal of the American Society of Nephrology
- Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
- (2015) Olena Andrukhova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study
- (2015) M. Chonchol et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
- (2015) Nobuaki Ito et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure
- (2015) Ingrid A. Andersen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease
- (2015) Manish D. Sinha et al. PEDIATRIC NEPHROLOGY
- FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability
- (2014) Neerupma Silswal et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions
- (2014) J. C. Mason et al. EUROPEAN HEART JOURNAL
- FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis
- (2014) Lindsay M. Coe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Competitive Interaction Between Fibroblast Growth Factor 23 And Asymmetric Dimethylarginine in Patients With CKD
- (2014) G. Tripepi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
- (2014) J. Xie et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Kidney Is the Principal Organ Mediating Klotho Effects
- (2014) K. Lindberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Noncardiovascular mortality in CKD: an epidemiological perspective
- (2014) Dinanda J. de Jager et al. Nature Reviews Nephrology
- Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults
- (2013) Anna Jovanovich et al. ATHEROSCLEROSIS
- Correlates of left ventricular mass in chronic hemodialysis recipients
- (2013) Ron Wald et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
- (2013) Myles Wolf et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency
- (2013) Rika Jimbo et al. KIDNEY INTERNATIONAL
- Correction: Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients
- (2013) Kensaku Shibata et al. PLoS One
- Parathyroid-Specific Deletion of Klotho Unravels a Novel Calcineurin-Dependent FGF23 Signaling Pathway That Regulates PTH Secretion
- (2013) Hannes Olauson et al. PLoS Genetics
- Macrophages play a unique role in the plaque calcification by enhancing the osteogenic signals exerted by vascular smooth muscle cells
- (2012) Koji Ikeda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
- (2012) Kenneth Lim et al. CIRCULATION
- Fibroblast Growth Factor 23 and Inflammation in CKD
- (2012) J. Munoz Mendoza et al. Clinical Journal of the American Society of Nephrology
- Can features of phosphate toxicity appear in normophosphatemia?
- (2012) Satoko Osuka et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes
- (2012) Justine Bacchetta et al. JOURNAL OF BONE AND MINERAL RESEARCH
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted Deletion of Klotho in Kidney Distal Tubule Disrupts Mineral Metabolism
- (2012) H. Olauson et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Relationship of Fibroblast Growth Factor 23 with Left Ventricle Mass Index and Coronary Calcificaton in Chronic Renal Disease
- (2012) Abdulkadir Unsal et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet
- (2012) Wei Ling Lau et al. KIDNEY INTERNATIONAL
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
- (2011) M. Koizumi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Osteocyte primary cilium and its role in bone mechanotransduction
- (2010) Sara Temiyasathit et al. Annals of the New York Academy of Sciences
- Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
- (2010) M. G. Vervloet et al. Clinical Journal of the American Society of Nephrology
- FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
- (2010) Mahmut I. Yilmaz et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
- (2010) M. M. Nasrallah et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
- (2009) Heng Jung Hsu et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
- (2009) J. B. Wetmore et al. Clinical Journal of the American Society of Nephrology
- Screening for Albuminuria Identifies Individuals at Increased Renal Risk
- (2009) M. van der Velde et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule
- (2009) E. G. Farrow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease
- (2009) H. Galitzer et al. KIDNEY INTERNATIONAL
- Relationship between circulating FGF23 and total body atherosclerosis in the community
- (2009) Majd A. I. Mirza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endocrine functions of bone in mineral metabolism regulation
- (2008) L. Darryl Quarles JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search